Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

C Hendricks Brown, Wei Wang, Sheppard G Kellam, Bengt O Muthén, Hanno Petras, Peter Toyinbo, Jeanne Poduska, Nicholas Ialongo, Peter A Wyman, Patricia Chamberlain, Zili Sloboda, David P MacKinnon, Amy Windham, Prevention Science and Methodology Group
Author Information
  1. C Hendricks Brown: Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, 13201 Bruce B Downs Blvd., Tampa, FL 33612, United States. hbrown@health.usf.edu

Abstract

Randomized field trials provide unique opportunities to examine the effectiveness of an intervention in real world settings and to test and extend both theory of etiology and theory of intervention. These trials are designed not only to test for overall intervention impact but also to examine how impact varies as a function of individual level characteristics, context, and across time. Examination of such variation in impact requires analytical methods that take into account the trial's multiple nested structure and the evolving changes in outcomes over time. The models that we describe here merge multilevel modeling with growth modeling, allowing for variation in impact to be represented through discrete mixtures--growth mixture models--and nonparametric smooth functions--generalized additive mixed models. These methods are part of an emerging class of multilevel growth mixture models, and we illustrate these with models that examine overall impact and variation in impact. In this paper, we define intent-to-treat analyses in group-randomized multilevel field trials and discuss appropriate ways to identify, examine, and test for variation in impact without inflating the Type I error rate. We describe how to make causal inferences more robust to misspecification of covariates in such analyses and how to summarize and present these interactive intervention effects clearly. Practical strategies for reducing model complexity, checking model fit, and handling missing data are discussed using six randomized field trials to show how these methods may be used across trials randomized at different levels.

References

  1. Am J Community Psychol. 1999 Oct;27(5):711-31 [PMID: 10676545]
  2. Eval Rev. 2005 Apr;29(2):128-48 [PMID: 15731509]
  3. Am J Public Health. 2007 Sep;97(9):1644-9 [PMID: 17395843]
  4. Am J Community Psychol. 1991 Aug;19(4):563-84 [PMID: 1755436]
  5. Child Abuse Negl. 2006 Apr;30(4):409-24 [PMID: 16600372]
  6. Biostatistics. 2002 Dec;3(4):459-75 [PMID: 12933592]
  7. J Consult Clin Psychol. 2006 Jun;74(3):500-10 [PMID: 16822107]
  8. Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S60-73 [PMID: 18329189]
  9. Psychol Methods. 2002 Jun;7(2):147-77 [PMID: 12090408]
  10. Am J Community Psychol. 1999 Oct;27(5):599-641 [PMID: 10676542]
  11. JAMA. 2005 Apr 6;293(13):1635-43 [PMID: 15811983]
  12. Biometrics. 1998 Mar;54(1):265-78 [PMID: 9544521]
  13. Biometrics. 1994 Dec;50(4):933-44 [PMID: 7787006]
  14. Biometrics. 2006 Dec;62(4):1025-36 [PMID: 17156276]
  15. Am J Community Psychol. 1991 Dec;19(6):809-36 [PMID: 1793090]
  16. Psychol Rev. 1993 Oct;100(4):674-701 [PMID: 8255953]
  17. Biostatistics. 2001 Dec;2(4):397-416 [PMID: 12933632]
  18. Neuropsychopharmacology. 1992 Jan;6(1):39-48; discussion 49-63 [PMID: 1571068]
  19. Am J Community Psychol. 1999 Oct;27(5):673-710 [PMID: 10676544]
  20. Psychol Methods. 2001 Mar;6(1):18-34 [PMID: 11285809]
  21. Stat Methods Med Res. 1995 Sep;4(3):187-96 [PMID: 8548102]
  22. Am Psychol. 1999 Sep;54(9):755-64 [PMID: 10510665]
  23. Arch Gen Psychiatry. 2002 Oct;59(10):877-83 [PMID: 12365874]
  24. Dev Psychopathol. 2001 Spring;13(2):355-75 [PMID: 11393651]
  25. J Consult Clin Psychol. 2003 Jun;71(3):587-600 [PMID: 12795581]
  26. Psychol Methods. 2006 Mar;11(1):36-53 [PMID: 16594766]
  27. J Consult Clin Psychol. 2005 Apr;73(2):229-38 [PMID: 15796630]
  28. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1003-1014 [PMID: 17667479]
  29. J Consult Clin Psychol. 2008 Feb;76(1):104-15 [PMID: 18229988]
  30. Biometrics. 1996 Dec;52(4):1324-33 [PMID: 8962456]
  31. Psychol Methods. 2001 Dec;6(4):330-51 [PMID: 11778676]
  32. Control Clin Trials. 2000 Jun;21(3):167-89 [PMID: 10822117]
  33. J Acquir Immune Defic Syndr (1988). 1990;3 Suppl 2:S120-3 [PMID: 2231292]
  34. Psychol Methods. 2003 Sep;8(3):369-77; discussion 384-93 [PMID: 14596497]
  35. Clin Trials. 2006;3(3):259-71 [PMID: 16895043]
  36. Psychopharmacol Bull. 1988;24(3):438-43 [PMID: 3153505]
  37. J Natl Cancer Inst. 1985 Mar;74(3):543-51 [PMID: 3883037]
  38. Biometrics. 1988 Dec;44(4):1049-60 [PMID: 3233245]
  39. Am J Community Psychol. 1999 Aug;27(4):463-82 [PMID: 10573831]
  40. Prev Sci. 2006 Mar;7(1):43-56 [PMID: 16572301]
  41. Dev Psychopathol. 1998 Spring;10(2):165-85 [PMID: 9635220]
  42. Biometrics. 1997 Dec;53(4):1527-37 [PMID: 9423267]
  43. Prev Sci. 2005 Sep;6(3):151-75 [PMID: 16365954]
  44. Am J Prev Med. 2002 Aug;23(2 Suppl):92-7 [PMID: 12133743]
  45. Biostatistics. 2006 Jan;7(1):29-40 [PMID: 15923407]
  46. New Dir Child Adolesc Dev. 2001 Spring;(91):79-92 [PMID: 11280015]
  47. Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S29-44 [PMID: 18249508]
  48. Biometrics. 1999 Jun;55(2):463-9 [PMID: 11318201]
  49. Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S5-S28 [PMID: 18343607]
  50. Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S45-59 [PMID: 18243581]
  51. Clin Psychol Rev. 1998 Jan;18(1):23-45 [PMID: 9455622]
  52. Psychol Methods. 2003 Sep;8(3):338-63 [PMID: 14596495]
  53. Prev Med. 1986 Sep;15(5):451-74 [PMID: 3534875]
  54. J Psychiatr Res. 1999 Mar-Apr;33(2):87-95 [PMID: 10221740]
  55. Arch Pediatr Adolesc Med. 2005 Jan;159(1):25-31 [PMID: 15630054]
  56. Psychol Methods. 2006 Dec;11(4):323-43 [PMID: 17154750]
  57. Psychol Methods. 2000 Jun;5(2):199-213 [PMID: 10937329]
  58. J Consult Clin Psychol. 2004 Aug;72(4):617-24 [PMID: 15301646]
  59. Stat Med. 1993 Feb;12(3-4):289-300 [PMID: 7681214]
  60. Am J Community Psychol. 1993 Oct;21(5):635-64 [PMID: 8192125]
  61. Prev Sci. 2007 Sep;8(3):206-13 [PMID: 17549635]
  62. Biometrics. 2002 Mar;58(1):21-9 [PMID: 11890317]
  63. J Early Intensive Behav Interv. 2007 Jan 15;4(4):681-702 [PMID: 19043620]
  64. Eval Rev. 1999 Aug;23(4):418-44 [PMID: 10558394]
  65. J Biopharm Stat. 2001 Nov;11(4):253-73 [PMID: 12018779]
  66. J Am Acad Child Adolesc Psychiatry. 2004 Jan;43(1):88-96 [PMID: 14691364]
  67. Am J Community Psychol. 1991 Dec;19(6):837-46 [PMID: 1793091]
  68. Am J Psychiatry. 2006 Nov;163(11):1905-17 [PMID: 17074942]
  69. Stat Methods Med Res. 1999 Mar;8(1):3-15 [PMID: 10347857]
  70. Biometrics. 2007 Sep;63(3):699-707 [PMID: 17825003]
  71. JAMA. 2002 Oct 16;288(15):1874-81 [PMID: 12377086]
  72. Am J Community Psychol. 1999 Aug;27(4):483-517 [PMID: 10573832]
  73. Stat Med. 1994 Mar 15-Apr 15;13(5-7):587-601 [PMID: 7517570]
  74. Arch Gen Psychiatry. 1999 Dec;56(12):1088-96 [PMID: 10591284]
  75. J Stud Alcohol. 2000 Mar;61(2):290-300 [PMID: 10757140]
  76. J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):790-7 [PMID: 16034281]
  77. Int Rev Psychiatry. 2007 Dec;19(6):617-31 [PMID: 18092240]
  78. J Epidemiol Community Health. 2001 Feb;55(2):111-22 [PMID: 11154250]

Grants

  1. R01 MH040859-15S1/NIMH NIH HHS
  2. R01 MH068423/NIMH NIH HHS
  3. R01 MH068423-02/NIMH NIH HHS
  4. R01 MH068423-03/NIMH NIH HHS
  5. T32 MH018834-19/NIMH NIH HHS
  6. R01 MH040859-11/NIMH NIH HHS
  7. R34 MH071189-02/NIMH NIH HHS
  8. P50 MH 38725/NIMH NIH HHS
  9. R01 DA015409-03S2/NIDA NIH HHS
  10. K02 AA000230-06/NIAAA NIH HHS
  11. T32 MH018834-13/NIMH NIH HHS
  12. K02 AA000230/NIAAA NIH HHS
  13. R01 MH068423-01A2/NIMH NIH HHS
  14. R01 MH042968-13/NIMH NIH HHS
  15. R01 MH040859-14/NIMH NIH HHS
  16. R01 MH040859-14S1/NIMH NIH HHS
  17. K02 AA000230-10/NIAAA NIH HHS
  18. T32 MH018834-18/NIMH NIH HHS
  19. P30 MH068685-03/NIMH NIH HHS
  20. R01 MH042968-11A1/NIMH NIH HHS
  21. R01 DA019984-02S1/NIDA NIH HHS
  22. R01 MH040859-15/NIMH NIH HHS
  23. R01 DA019984/NIDA NIH HHS
  24. R01 MH076158-02/NIMH NIH HHS
  25. R01 MH040859/NIMH NIH HHS
  26. R34 MH071189/NIMH NIH HHS
  27. T32 MH018834-12/NIMH NIH HHS
  28. P50 MH038725-08/NIMH NIH HHS
  29. R01 MH040859-19/NIMH NIH HHS
  30. K02 AA000230-04/NIAAA NIH HHS
  31. P20 DA017592-01/NIDA NIH HHS
  32. T32 MH018834-14/NIMH NIH HHS
  33. R01 MH042968-12/NIMH NIH HHS
  34. R01 DA015409-04/NIDA NIH HHS
  35. R01 DA015409-04S1/NIDA NIH HHS
  36. R34 MH071189-03/NIMH NIH HHS
  37. T32 MH018834/NIMH NIH HHS
  38. R01 DA01998-02S1/NIDA NIH HHS
  39. K02 AA00230/NIAAA NIH HHS
  40. R01 MH040859-16/NIMH NIH HHS
  41. K02 AA000230-05/NIAAA NIH HHS
  42. K02 AA000230-08/NIAAA NIH HHS
  43. R01 MH 40859/NIMH NIH HHS
  44. R01 MH076158-01A1/NIMH NIH HHS
  45. P20 DA017592-02/NIDA NIH HHS
  46. T32 MH018834-17/NIMH NIH HHS
  47. R01 MH 42968/NIMH NIH HHS
  48. R01 MH040859-18/NIMH NIH HHS
  49. R01 DA015409-03/NIDA NIH HHS
  50. R01 DA015409-05/NIDA NIH HHS
  51. P20 DA017592/NIDA NIH HHS
  52. T32 MH018834-15/NIMH NIH HHS
  53. K02 AA000230-09/NIAAA NIH HHS
  54. P30 MH068685/NIMH NIH HHS
  55. R01 DA015409-02/NIDA NIH HHS
  56. R01 MH042968-10/NIMH NIH HHS
  57. P30 MH068685-01A2/NIMH NIH HHS
  58. R01 MH040859-13/NIMH NIH HHS
  59. R01 MH076158/NIMH NIH HHS
  60. R01 MH040859-17/NIMH NIH HHS
  61. R01 MH040859-12A1/NIMH NIH HHS
  62. R34 MH071189-01/NIMH NIH HHS
  63. T32 MH018834-16/NIMH NIH HHS
  64. R01 MH042968/NIMH NIH HHS
  65. R01 DA015409-01/NIDA NIH HHS
  66. T32 MH018834-11/NIMH NIH HHS
  67. R01 DA015409/NIDA NIH HHS
  68. P30 MH068685-02/NIMH NIH HHS
  69. K02 AA000230-07/NIAAA NIH HHS

MeSH Term

Adolescent
Adult
Attention Deficit and Disruptive Behavior Disorders
Baltimore
Behavior Therapy
Child
Data Interpretation, Statistical
Humans
Longitudinal Studies
Models, Statistical
Outcome Assessment, Health Care
Randomized Controlled Trials as Topic
Research Design
Schools
Socialization
Substance-Related Disorders
Violence

Word Cloud

Created with Highcharts 10.0.0impacttrialsfieldexamineinterventionvariationmodelstesttheorytimemethodsmultilevelanalysesrandomizedoverallacrossdescribemodelinggrowthmixtureintent-to-treatmodelRandomizedprovideuniqueopportunitieseffectivenessrealworldsettingsextendetiologydesignedalsovariesfunctionindividuallevelcharacteristicscontextExaminationrequiresanalyticaltakeaccounttrial'smultiplenestedstructureevolvingchangesoutcomesmergeallowingrepresenteddiscretemixtures--growthmodels--andnonparametricsmoothfunctions--generalizedadditivemixedpartemergingclassillustratepaperdefinegroup-randomizeddiscussappropriatewaysidentifywithoutinflatingTypeerrorratemakecausalinferencesrobustmisspecificationcovariatessummarizepresentinteractiveeffectsclearlyPracticalstrategiesreducingcomplexitycheckingfithandlingmissingdatadiscussedusingsixshowmayuseddifferentlevelsMethodstestingevaluatingtrials:integratingperspectivespersonplace

Similar Articles

Cited By